SPOTLIGHT: Inventor wins $431M from Boston Sci


A Texas jury ruled that Boston Scientific's drug-coated stents violate a 1997 patent and awarded $431 million to patent holder Dr. Bruce N. Saffran. Confident it can win on appeal, the company won't set aside money to pay the damages. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.